Related Experiment Video
Updated: Feb 23, 2026
09:17
Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions
Published on: August 2, 2018
18.8K
Polo-like kinase 3, hypoxic responses, and tumorigenesis
Dazhong Xu1, Wei Dai2, Cen Li1
1a Department of Pathology , New York Medical College School of Medicine , Valhalla , NY , USA.
Cell Cycle (Georgetown, Tex.)
|September 1, 2017
Summary
Polo-like kinase 3 (Plk3) suppresses tumor progression by destabilizing Hypoxia-Inducible Factor 1-alpha (HIF-1α). Plk3 and SIAH2 mutually regulate each other, fine-tuning the cellular hypoxic response and impacting tumorigenesis.
Area of Science:
- Molecular Biology
- Cellular Biology
- Oncology
Background:
- The cellular hypoxic response is crucial for tumor progression.
- Hypoxia-Inducible Factor 1 (HIF-1) regulates genes essential for adaptation to low oxygen.
- HIF-1α protein levels are tightly controlled by oxygen-dependent degradation and protein kinases.
Purpose of the Study:
- To investigate the role of Polo-like kinase 3 (Plk3) in regulating the hypoxic response.
- To elucidate the interaction between Plk3, SIAH2, and HIF-1α.
- To understand the implications of these interactions in tumorigenesis.
Main Methods:
- Investigated Plk3's tumor suppressive function.
- Analyzed Plk3's phosphorylation and stabilization of PTEN.
- Identified SIAH2 as the E3 ubiquitin ligase for Plk3 and studied their mutual regulation.
Main Results:
- Plk3 phosphorylates and destabilizes HIF-1α.
- Plk3 phosphorylates and stabilizes PTEN, affecting the PI3K pathway.
- Hypoxia/nickel suppresses Plk3 via ubiquitin-proteasome system.
- SIAH2 is the E3 ligase for Plk3; Plk3 destabilizes SIAH2.
- SIAH2 promotes HIF-1α stability.
Conclusions:
- A novel mutual regulatory mechanism exists between Plk3 and SIAH2.
- This Plk3-SIAH2 interaction fine-tunes the cellular hypoxic response.
- Plk3's role in hypoxic response and tumorigenesis is further clarified.
Related Concept Videos
01:22PI3K/mTOR/AKT Signaling Pathway
5.8K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.8K
03:03mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K
01:24Regulation of Angiogenesis and Blood Supply
3.8K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.8K
02:53Adaptive Mechanisms in Cancer Cells
7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
02:23Abnormal Proliferation
5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
01:19Interactions Between Signaling Pathways
7.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.4K